On September 5th, 2019, Dr. Tao Du, the chairman of Shenzhen Evergreen Therapeutics Co., Ltd., went to the famous Meakins-Christie Laboratories (MCL) of McGill University of Canada, known as the most prestigious respiratory disease institute in the world, for academic exchange activities with his team. Dr. Tao Du and team members discussed collaboration in respiratory disease research with Professor James G Martin, former director of MCL and current leader of internal medicine at McGill University School of Medicine. Both determined that research will be carried out in the fields of respiratory rare diseases and asthma and agreed to have in depth cooperation in clinical trials of respiratory rare diseases.

Professor James G Martin has 35 years of clinical and scientific experience in the field of respiratory diseases and has published as many as 200 scientific papers in the world's top academic journals. At the end of the meeting, Professor James Martin led members of Evergreen team to visit the laboratory and the animal experiment base at MCL. Dr. Du Tao said, "It’s the size of MCL, the high level of scientific research, and the ability to combine with clinical practice that make it the leader in the world. As a global company committed to the development of innovative respiratory drugs, Evergreen will carry out close cooperation with MCL in the next few years, so as to develop the new drug products that are urgently needed in clinical practices as soon as possible ".